Value of Screening and Treatment of SAHS in the Management of AF Ablation Candidates
Recruiting
N/A
Interventional Study
Atrial Fibrillation Paroxysmal
Atrial Fibrillation, Persistent
Apnea Syndrome
Hypopnea Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 50 (estimated)
- Sponsor
- Hospital San Carlos, Madrid · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The present prospective cohort study (not randomized) analyses the value of screening and treatment of SAHS in the management of patients with AF refractory to antiarrhythmics drugs, potentially candidates for ablation.
Patients at low risk of suffering from SAHS will follow conventional management of their AF, according to the usual criteria of the Arrhythmia Unit. Patients with high or intermed…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with paroxysmal or persistent atrial fibrillation
* Recurrent atrial fibrillation despite treatment with at least one class I or III antiarrhythmic
* No previous diagnosis of apnea-hypopnea syndrome
Exclusion Criteria:
* Patients \<18 years
* Pregnant women
* Doubts…
Contacts